SANDRA NASSER: Open Payments
NPI 1184260077 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 38 payments from 15 companies in 2025. Trend: 2023 $859 · 2024 $659 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $146 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| Amgen Inc. | 4 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Lilly USA, LLC | 3 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
| Corcept Therapeutics | 1 | $24 |
Products named: Kerendia, REXULTI, Rybelsus, XIFAXAN, Ozempic, MOUNJARO, GEMTESA, Cologuard Collection Kit.
Industry payments across MI — which companies pay providers there.
